grants_govRFA-HG-27-013
Open
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
- Response deadline
- Oct 30, 2026 Due in 12 days
- Date posted
- Jun 18, 2026
- Source
- Open notice
Description
The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. This Notice of Funding Opportunity is intended to stimulate the development and testing of highly innovative experimental or computational approaches for rare disease diagnosis, that have the potential to make transformative improvements to the current state of the art.
Classifications
- NAICS93.172
Documents (1)
- DownloadRFA-HG-27-013-Full-Announcement.htmltext/html;charset=UTF-8143 KB
Contacts
Similar contracts
- IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)Due Dec 14, 2026
- Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)Due Dec 14, 2026
- Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)Due Dec 14, 2026
- Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)Due Dec 14, 2026
- GREGoRi Technology Integration Center (U01, Clinical Trials Optional)Due Oct 30, 2026
- GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)Due Oct 30, 2026